Corautus Genetics
Corautus Genetics: quarterly report for the quarter ended Jun 30, 2005
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001193125-05-166246
- Document
- 10-Q
- Exhibit 10.3
- Common stock purchase agreement
- Exhibit 10.4
- Investment agreement
- Exhibit 10.5
- Registration rights agreement
- Exhibit 10.6
- Third amendment to loan agreement
- Exhibit 10.7
- First amendment to distribution agreement
- Exhibit 10.8
- Second amendment to development agreement
- Exhibit 10.9
- Senior convertible promissory note (No. 004)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2836) and public float not reported.
- Adaptimmune Therapeutics ADAP
- Adverum Biotechnologies ADVM
- AgomAb Therapeutics AGMB
- Alvotech ALVO
- Argenx ARGX